Global /South Korea /Healthcare /Medical Devices /023910

Daihan Pharmaceutical Co.,Ltd.

023910

• KRX: 023910 • Delayed

28,650KRW -1.2%

18.69 USD

As of 5 June 2026, Daihan Pharmaceutical Co.,Ltd. has a market cap of $111.25M USD, ranking #24822 globally and #1160 in South Korea. It ranks #2219 in the Healthcare sector, and #456 in the Medical Devices industry.

Global Rank

24822

Country Rank

1160

Sector Rank

2219

Industry Rank

456

Key Stats

Market Cap

$111.25MUSD

170.52B KRW

Enterprise Value

$52.84MUSD

81.0B KRW

Revenue (TTM)

$136.1MUSD

208.61B KRW

EBITDA (TTM)

$26.36MUSD

40.41B KRW

Net Income (TTM)

$18.03MUSD

27.64B KRW

EBITDA Margin

19%

Profit Margin

13%

PE Ratio

6.2

Forward PE

5.2

PS Ratio

0.8

PB Ratio

0.6

EV/EBITDA

2.0

Company Profile

Country (HQ)

South Korea

Sector

Healthcare

Industry

Medical Devices

CEO

Sungyoung Lee open_in_new

Employees

553

Founded

1945

Website

daihan.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
-1.2%	-1.2%	-1.2%	-1.2%	-2.2%	-2.1%	9.4%	2.5%	-32%

News

Markets

Exchange	Ticker	Price	Quotes
Korea Exchange (KRX) MIC: XKRX PRIMARY	023910 대한약품공업(주) ISIN: KR7023910003 Shares Out.: Shares Outstanding: 5.88M¹ Shares Float: 3.43M² TV: TradingView: KRX: 023910 SA: Stock Analysis: KRX: 023910 YF: Yahoo Finance: 023910.KS GF: Google Finance: KRX: 023910 BA: Barron's: 023910 MS: Morningstar: XKRX: 023910	28,650 KRW	TV: TradingView: KRX: 023910 SA: Stock Analysis: KRX: 023910 YF: Yahoo Finance: 023910.KS GF: Google Finance: KRX: 023910 BA: Barron's: 023910 MS: Morningstar: XKRX: 023910

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Daihan Pharmaceutical Co.,Ltd.

Daihan Pharmaceutical Co.,Ltd. engages in the manufacture and sale of therapeutic drugs in South Korea. The company offers various drugs, such as prescription, OTC, and quasi drugs, as well as offers various infusion related solutions. Daihan Pharmaceutical Co.,Ltd. was founded in 1945 and is headquartered in Seoul, South Korea.

Similar Companies

Industry: Medical Devices (South Korea)

Name	Market Cap (USD) diff.	PE	Country
CLASSYS Inc. KRX: 214150	$2.45B 3.75T KRW 2K%	28.7	South Korea
SEERS Co., Ltd. KRX: 458870	$1.22B 1.86T KRW 994%	114.8	South Korea
Livsmed Inc. KRX: 491000	$1.18B 1.81T KRW 961%	-	South Korea
L&C BIO Co.,LTD KRX: 290650	$1.13B 1.74T KRW 919%	-	South Korea
Seegene, Inc. KRX: 096530	$753.63M 1.16T KRW 577%	23.9	South Korea
i3system Inc. KRX: 214430	$528.2M 809.64B KRW 375%	83.3	South Korea

Industry: Medical Devices (Global)

Name	Market Cap (USD) diff.	PE	Country
Thermo Fisher Scientific Inc. NYSE: TMO	$173.27B 156K%	25.8	United States
Intuitive Surgical, Inc. NASDAQ: ISRG	$160.73B 144K%	56.7	United States
Abbott Laboratories NYSE: ABT	$159.07B 143K%	25.6	United States
Danaher Corp. NYSE: DHR	$126.55B 114K%	34.7	United States
Stryker Corp. NYSE: SYK	$120.69B 108K%	38.3	United States
Medtronic plc NYSE: MDT	$101.9B 92K%	22.2	Ireland

chevron_leftBack